APA

Mezeiova E., Korabecny J., Sepsova V., Hrabinova M., Jost P., Muckova L., Kucera T., Dolezal R., Misik J., Spilovska K., Pham N. L., Pokrievkova L., Roh J., Jun D., Soukup O., Kaping D. & Kuca K. (20180423). Development of 2-Methoxyhuprine as Novel Lead for Alzheimer's Disease Therapy. : Molecules (Basel, Switzerland).

Chicago

Mezeiova Eva, Korabecny Jan, Sepsova Vendula, Hrabinova Martina, Jost Petr, Muckova Lubica, Kucera Tomas, Dolezal Rafael, Misik Jan, Spilovska Katarina, Pham Ngoc Lam, Pokrievkova Lucia, Roh Jaroslav, Jun Daniel, Soukup Ondrej, Kaping Daniel and Kuca Kamil. 20180423. Development of 2-Methoxyhuprine as Novel Lead for Alzheimer's Disease Therapy. : Molecules (Basel, Switzerland).

Harvard

Mezeiova E., Korabecny J., Sepsova V., Hrabinova M., Jost P., Muckova L., Kucera T., Dolezal R., Misik J., Spilovska K., Pham N. L., Pokrievkova L., Roh J., Jun D., Soukup O., Kaping D. and Kuca K. (20180423). Development of 2-Methoxyhuprine as Novel Lead for Alzheimer's Disease Therapy. : Molecules (Basel, Switzerland).

MLA

Mezeiova Eva, Korabecny Jan, Sepsova Vendula, Hrabinova Martina, Jost Petr, Muckova Lubica, Kucera Tomas, Dolezal Rafael, Misik Jan, Spilovska Katarina, Pham Ngoc Lam, Pokrievkova Lucia, Roh Jaroslav, Jun Daniel, Soukup Ondrej, Kaping Daniel and Kuca Kamil. Development of 2-Methoxyhuprine as Novel Lead for Alzheimer's Disease Therapy. : Molecules (Basel, Switzerland). 20180423.